Description
Molecular diagnostics is becoming a dominant platform in clinical medicine and represents one of the fastest growing segments of the diagnostics market. Many molecular tests are CE Marked and FDA-cleared and many more are in development. However many more unique tests have been launched as test services, especially for cancer management and infectious disease epidemiology.
In light of the amount of activity in test development and regulatory and reimbursement challenges in 2013, Kalorama Information presents this updated review of molecular diagnostics with an emphasis on the last six months of 2013: July – December. This report highlights trends and developments that portent the evolution of molecular tests and technologies. The ensemble of consumer demand, technological advances and market forces create a dynamic, energetic and fast-moving environment for new tests and companies.
Though focused on the developments of the last six months, coverage is substantial. As part of its coverage, this report provides, current market size and forecasts for Molecular Diagnostic Segments, including:
-Microbiology
-Histology
-Blood Screening
-Prenatal
-Coagulation
-Inherited Diseases
-Tissue Typing
-Cancer Markers
-Pharmacodiagnostics
– CTCs
The report provides breakout of key market segments for molecular diagnostic markets in world regions, including developed nations and emerging nations. In addition the following important trend information is also provided:
-Selected Sequencing-Based Innovations July-December 2013
-Selected Molecular Diagnostics Collaborations, July-December 2013
-Selected Molecular Diagnostics Licensing Agreements, July-December 2013
-Selected Molecular Diagnostics Distribution Agreements, July-December 2013
-Regulatory and Reimbursement Update
-Molecular Test Revenues of The Top Companies, 2012-2013
Market analysis in this report covers world markets for in vitro diagnostics, however the reader will find a bias toward the developed areas of the globe — North America and Western Europe. However public health and infectious disease are a growing global problem and where possible the report covers IVD products related to the globalization of diseases. The information presented in this report is derived primarily from company reports and other publicly available information published by government, and medical organizations.
Table of Contents
CHAPTER ONE: MARKET OVERVIEW
Background
Scope and Methodology
Size And Growth Of The Market, Worldwide
Regulatory and Reimbursement Update
Company Moves
Top Suppliers and Niche players
Test Services Continue to Expand
Point of View
CHAPTER TWO: SEQUENCING MOVES TO THE CLINIC
Background
Cancer gets more personal
Pathogen sequencing
CHAPTER THREE: THE MARKET FOR BLOOD-BASED MARKERS IN CANCER
Background
Blood-based analyses
Circulating Tumor Cells
CHAPTER FOUR: THE MARKET FOR MOLECULAR ASSAYS IN HEMATOLOGY
Background
CHAPTER FIVE: THE MARKET FOR MOLECULAR ASSAYS IN COAGULATION AND CARDIAC CARE
Background
Coagulation Market Analysis
CHAPTER SIX: THE MARKET FOR MOLECULAR ASSAYS IN HISTOPATHOLOGY/CYTOLOGY
Background
Molecular Histology
Market Analysis
HPV Testing
CHAPTER SEVEN: THE MARKET FOR MOLECULAR ASSAYS IN MICROBIOLOGY/VIROLOGY
Overview
HIV/AIDS
Hepatitis
Sexually Transmitted Diseases
Hospital Acquired Infections
Respiratory Tract Infections
Tuberculosis
Blood Culture
Miscellaneous
Mass Spectrometry
CHAPTER EIGHT: THE MARKET FOR MOLECULAR ASSAYS IN BLOOD TRANSFUSION SCREENING
Background
Blood Pathogen Screening
Blood Typing
CHAPTER NINE: THE MARKET FOR MOLECULAR ASSAYS IN BLOOD TRANSFUSION SCREENING
Background
Blood Pathogen Screening
Blood Typing
CHAPTER TEN: The Market For Molecular Assays For Inherited Diseases
Market Analysis
CHAPTER ELEVEN: The Market For Molecular Assays In Organ Transplant
Management
Market Analysis
CHAPTER TWELVE: The Market For Molecular Assays
In Prenatal And Neonatal Testing
Market Analysis
CHAPTER THIRTEEN: Forecast: An Eye For The Next Six Months
– January To June 2014
Market Analysis
CHAPTER ONE: MARKET OVERVIEW
Table 1-1: Exchange Rate Fluctuations, 2009-2013
Table 1-2: Worldwide Molecular Test Sales, 2012-2013, by Test Segment (Growth Rates in
Molecular Diagnostics Compared (Microbiology, Histology, Blood Screening, Prenatal,
Coagulation, Inherited Diseases, Tissue Typing, Cancer Markers, Pharmacodiagnostics, CTCs)
Table 1-3: Worldwide Molecular Test Sales, 2012-2013, By Geography (North America, Western Europe, Japan, China, Latin America, ROW)
Table 1-3: Worldwide Molecular Test Sales, 2012-2013, By Geography (North America, Western Europe, Japan, China, Latin America, ROW)
Table 1-4: Selected Advanced Test Innovations, July –December 2013
Table 1-5: Selected Company Purchases And Joint Ventures, July-December 2013
Table 1-6: Selected collaborations, July-December 2013
Table 1-7: Selected licensing agreements, July-December 2013
Table 1-8: Selected distribution agreements, July-December 2013
Table 1-9: Molecular Test Revenues of The Top Companies, 2012-2013
Table 1-9: Molecular Test Revenues of The Top Companies, 2012 Vs. 2013
Table 1-10: Selected Molecular Test Services, Sales 2012-2013
Table 1-11: Selected Molecular Test Services, July-December 2013
CHAPTER TWO: SEQUENCING MOVES TO THE CLINIC
Table 2-1: Major Sequencing Platforms
Table 2-2: Selected Sequencing-Based Innovations July-December 2013
CHAPTER THREE: THE MARKET FOR BLOOD-BASED MARKERS IN CANCER
Table 3-1: Selected Innovation In Blood-Based Cancer Tests, July-December 2013
Table 3-2: Selected Non-Invasive Molecular Cancer Tests In Development, July-December 2013
Table 3-3: Selected Innovations In Circulating Tumor Cell Testing, July-December 2013
CHAPTER FOUR: THE MARKET FOR MOLECULAR ASSAYS IN HEMATOLOGY
Table 4-1: Selected Innovations In Molecular Hematological Tests, July-December 2013
CHAPTER FIVE: THE MARKET FOR MOLECULAR ASSAYS IN COAGULATION AND CARDIAC CARE
Table 5-1: Selected Tests For Coagulation And Cardiac Disease Molecular Markers July- December 2013
CHAPTER SIX: THE MARKET FOR MOLECULAR ASSAYS IN HISTOPATHOLOGY/CYTOLOGY
Table 6-1: Worldwide Molecular Histology/Cytology Sales, 2012-2013
Table 6-2: Selected Molecular Histology Innovations, July-December 2013
Table 6-3: Selected Innovations In Molecular Tissue Sample Preparation, July – December 2013
Table 6-4: Selected Innovations In HPV Testing, July –December 2013
CHAPTER SEVEN: THE MARKET FOR MOLECULAR ASSAYS IN MICROBIOLOGY/VIROLOGY
Table 7-1: Molecular Test Sales, Microbiolog/Virology, 2012-2013
Table 7-2: Selected Hepatitis Test Innovations, July-December 2013
Table 7-3: Selected Innovations In Molecular STD Testing, July-December 2013
Table 7-4: Selected Molecular HAI Test Innovations, July-December 2013
Table 7-5: Selected Respiratory Tract Test Innovations, July-December 2013
Table 7-6: Selected Microbiology Innovations, July-December 2013
CHAPTER NINE: THE MARKET FOR MOLECULAR ASSAYS FOR INHERITED DISEASES
Table 9-1: Selected Innovations In Molecular Tests For Inherited Diseases, July – December 2013
CHAPTER ELEVEN: The Market For Molecular Assays In Organ Transplant Management
Table 11-1: Selected Innovations In Prenatal Testing, July-December 2013
